Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
jNc3d1Kdns1PKyHV